MISC

2019年5月

Improvement of non-alcoholic fatty liver disease after laparoscopic sleeve gastrectomy in Japanese obese patients.

Annals of gastroenterological surgery
  • Yuichi Endo
  • Masayuki Ohta
  • Kazuhiro Tada
  • Hiroaki Nakanuma
  • Kunihiro Saga
  • Takashi Masuda
  • Teijiro Hirashita
  • Yukio Iwashita
  • Yoshinori Ozeki
  • Takayuki Masaki
  • Masafumi Inomata
  • 全て表示

3
3
開始ページ
285
終了ページ
290
記述言語
英語
掲載種別
DOI
10.1002/ags3.12234

Purpose: The purpose of this study was to evaluate changes in non-alcoholic fatty liver disease (NAFLD) after laparoscopic sleeve gastrectomy (LSG) using computed tomography (CT) images. Methods: We analyzed data from 57 patients who underwent LSG and had CTs performed before and after surgery. The patients included 34 women and 23 men (with an average age of 43 years); their mean preoperative weight and body mass index were 120 kg and 46 kg/m2, respectively. Obesity-related health disorders included type 2 diabetes mellitus (T2DM) in 33 patients, hypertension in 33 and dyslipidemia in 32. We diagnosed NAFLD in cases with liver to spleen ratios (L/S ratio) <0.9 on non-contrast CT images. We evaluated changes in body weights, BMIs, comorbidities, metabolic parameters, L/S ratios, and liver volumes after surgery. Results: The mean interval between CT scans before and after surgery was 26 months. The total weight loss and % excess weight loss were 35 kg and 72%, respectively. The remission rates for T2DM, hypertension, and dyslipidemia were 85%, 76% and 84%, respectively. After LSG, the L/S ratio increased in all the patients, while all except for one had L/S ratio >0.9. We diagnosed 33 out of 57 patients (58%) as having NAFLD before the operation. After the operation, the L/S ratios and liver volumes were not statistically different between the patients with previous NAFLD and those without it. Conclusion: Laparoscopic sleeve gastrectomy is an effective treatment for obesity-related health disorders including NAFLD in Japanese obese patients.

リンク情報
DOI
https://doi.org/10.1002/ags3.12234
PubMed
https://www.ncbi.nlm.nih.gov/pubmed/31131357
PubMed Central
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6524101
ID情報
  • DOI : 10.1002/ags3.12234
  • PubMed ID : 31131357
  • PubMed Central 記事ID : PMC6524101

エクスポート
BibTeX RIS